World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
107
Citations
61755
World Ranking
538
National Ranking
21

Medicine

D-Index
107
Citations
61755
World Ranking
6117
National Ranking
233

Research.com Recognitions

  • 2022 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award

Overview

Bart L. Haagmans is affiliated with Erasmus University Rotterdam in the Netherlands. Their primary field of study is Medicine with a specialized focus on Infectious Diseases, Epidemiology, Animal Science and Zoology, Molecular Biology, and Modeling and Simulation. The scientist has contributed extensively to research on SARS-CoV-2 and COVID-19, encompassing studies on COVID-19 clinical research, SARS-CoV-2 detection and testing, animal virus infections, respiratory viral infections, viral gastroenteritis, and COVID-19 epidemiological studies.

They have published numerous papers in various scientific venues, with frequent publications appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature Medicine
  • Science Immunology
  • Science

Notable recent papers authored or co-authored by the scientist include:

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, 2020, Eurosurveillance
  • The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, 2020, Nature Microbiology
  • Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients, 2020, Emerging infectious diseases
  • SARS-CoV-2 productively infects human gut enterocytes, 2020, Science
  • Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Bart L. Haagmans collaborates frequently with a number of co-authors in their research. Key collaborators include:

  • Mart M. Lamers
  • Marion Koopmans
  • Anna Z. Mykytyn
  • Nisreen M.A. Okba
  • Corine H. GeurtsvanKessel

The scientist's research topics cover a broad range of subjects related to viral infectious diseases with a significant emphasis on the SARS-CoV-2 virus and the COVID-19 pandemic. Their work includes studies on detection and testing techniques, clinical research into COVID-19 patient responses, investigations into animal virus infections, as well as epidemiological analyses of outbreaks.

In recognition of their contributions, Bart L. Haagmans received the European Society for Clinical Microbiology and Infectious Diseases Excellence Award in 2022.

Best Publications

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

    Victor M. Corman;Olfert Landt;Marco Kaiser;Richard Molenkamp

  • The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

    Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot

  • Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

    V. Stalin Raj;Huihui Mou;Saskia L. Smits;Dick H. W. Dekkers

  • Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

    Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot

  • SARS-CoV-2 productively infects human gut enterocytes.

    Mart M. Lamers;Joep Beumer;Jelte van der Vaart;Kèvin Knoops

  • Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

    Nisreen M.A. Okba;Marcel A. Müller;Wentao Li;Chunyan Wang

  • A human monoclonal antibody blocking SARS-CoV-2 infection.

    Chunyan Wang;Wentao Li;Dubravka Drabek;Nisreen M.A. Okba

  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.

    Philip J. M. Brouwer;Tom G. Caniels;Karlijn van der Straten;Jonne L. Snitselaar

  • Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans

    Sander van Boheemen;Miranda de Graaf;Chris Lauber;Theo M. Bestebroer

  • Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

    Barry Rockx;Thijs Kuiken;Sander Herfst;Theo Bestebroer

  • SARS-CoV-2 pathogenesis

    Unknown

  • Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.

    Daniela Weiskopf;Katharina S. Schmitz;Matthijs P. Raadsen;Alba Grifoni

  • Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

    Chantal B.E.M. Reusken;Bart L. Haagmans;Marcel A. Müller;Carlos Gutierrez

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation

    Bart L. Haagmans;Said H.S. Al Dhahiry;Chantal B.E.M. Reusken;V. Stalin Raj

  • Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).

    Jeroen J. A. van Kampen;David A. M. C. van de Vijver;Pieter L. A. Fraaij;Bart L. Haagmans

  • Virology: SARS virus infection of cats and ferrets.

    Byron E. E. Martina;Bart L. Haagmans;Thijs Kuiken;Ron A. M. Fouchier

  • Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells

    Vedashree Ramakrishnaiah;Christine Thumann;Isabel Fofana;Francois Habersetzer

  • SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.

    Daryl Geers;Marc C Shamier;Susanne Bogers;Gerco den Hartog

  • The emerging role of ACE2 in physiology and disease

    Inge Hamming;M. E. Cooper;B. L. Haagmans;N. M. Hooper

  • Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

    Bart L. Haagmans;Thijs Kuiken;Byron Ee E Martina;Ron Am M Fouchier

  • Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

    Victor Corman;Marcel Müller;U. Costabel;J. Timm

Frequent Co-Authors

Albert D. M. E. Osterhaus
Albert D. M. E. Osterhaus University of Veterinary Medicine Hannover, Foundation
Marion Koopmans
Marion Koopmans Erasmus University Rotterdam
V. Stalin Raj
V. Stalin Raj Erasmus University Rotterdam
Berend Jan Bosch
Berend Jan Bosch Utrecht University
Chantal Reusken
Chantal Reusken National Institute of Public Health and the Environment (RIVM)
Theo M. Bestebroer
Theo M. Bestebroer Erasmus University Rotterdam
Thijs Kuiken
Thijs Kuiken Erasmus University Rotterdam
Ron A. M. Fouchier
Ron A. M. Fouchier Erasmus University Rotterdam
Marian C. Horzinek
Marian C. Horzinek Utrecht University
Suzan D. Pas
Suzan D. Pas Radboud University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Many pursue nursing paths that complement Immunology knowledge, such as becoming a Nurse Practitioner with specialized expertise.

One popular route is to transition within nursing specialties. For those already licensed as Family Nurse Practitioners, advanced training through acnp programs can shift careers toward acute care settings, enhancing clinical skill sets in immunological and critical care contexts.

Applicants without a nursing background can still enter the field through pathways like online adn programs for non nurses, designed to build foundational clinical knowledge efficiently while accommodating non-traditional students.

For those looking to accelerate their nursing careers, accelerated nurse practitioner programs offer a fast-track to advanced practice roles, integrating critical immunology coursework vital for patient care in infectious and autoimmune diseases.

Furthermore, students seeking straightforward admissions can explore easiest absn programs to get into, providing quicker pathways to obtain a BSN degree and advance toward immunology-related healthcare careers.

Best Scientists Citing Bart L. Haagmans

Trending Scientists